Prof. Khalid Fakhro (left) and Dr. Ammira Al-Shabeeb Akil
Doha, Qatar: Sidra Medicine, a member of Qatar Foundation, has unveiled the official line-up of strategic partners, sponsors, and innovators participating in the upcoming Precision Medicine and the Future of Genomics (PMFG) Summit from December 2 to 4, 2025 at Qatar National Convention Centre (QNCC).
Chief Research Officer at Sidra Medicine, Prof. Khalid Fakhro said: “PMFG 2025 is a celebration of eleven years of scientific discovery and innovation in precision medicine. The summit highlights cutting-edge research and advances in genomics, healthcare technologies and clinical precision medicine implementation, bringing global expertise to the region.”
This year’s Summit will be held in collaboration with key institutional and industry partners including the Qatar Precision Health Institute (QPHI); the Ministry of Communications and Information Technology (MCIT); Children’s Hospital of Philadelphia (CHOP) and Mass General Brigham Hospital (MGB), serving as Knowledge Partners.
Scientific Outreach and Business Development Chair, PMFG Summit 2025, and Director of Mendelian and Metabolic Disorders Research Program, Dr. Ammira Al-Shabeeb Akil said: “Our focus has been on building the infrastructure that makes PMFG Summit 2025 a hub for innovation. From securing sponsors and partners to launching the Startups Hub, our goal is to give entrepreneurs and researchers the platform to showcase their work and translate ideas into real-world impact.”
President of Qatar Precision Health Institute Dr. Emmanouil Dermitzakis added: “Our partnership with Sidra Medicine for PMFG 2025 reflects a shared commitment to advancing precision health through innovation, collaboration, and real-world implementation. At QPHI, we believe that transforming healthcare begins with the integration of data, genomics, and technology to create impact at both the individual and population levels. ”
Director of the Digital Innovation Department at MCIT, Eman Al Kuwari said: “Our participation in PMFG 2025 reflects our commitment to fostering a strong digital innovation ecosystem, where emerging technologies including AI, big data, and cloud infrastructure drive advancements in precision medicine and genomics.”
